Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease.

paricalcitol polycystic kidney disease vitamin D receptor agonists

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
29 Oct 2021
Historique:
received: 04 09 2021
revised: 26 10 2021
accepted: 27 10 2021
entrez: 25 11 2021
pubmed: 26 11 2021
medline: 26 11 2021
Statut: epublish

Résumé

Vitamin D secosteroids are intranuclear regulators of cellular growth and suppress the renin-angiotensin system. The aim of this study was to test the hypothesis that the vitamin D receptor agonist, paricalcitol (PC), either alone or with enalapril (E) (an angiotensin-converting enzyme inhibitor), reduces the progression of polycystic kidney disease. Preventative treatment of Lewis polycystic kidney (LPK) and Lewis control rats with PC (0.2 μg/kg i.p. 5 days/week) or vehicle from postnatal weeks 3 to 10 did not alter kidney enlargement. To evaluate the efficacy in established disease, LPK rats received either PC (0.8 μg/kg i.p; 3 days/week), vehicle, E (50 mg/L in water) or the combination of PC + E from weeks 10 to 20. In established disease, PC also did not alter the progression of kidney enlargement, kidney cyst growth or decline in renal function in LPK rats. Moreover, the higher dose of PC was associated with increased serum calcium and weight loss. However, in established disease, the combination of PC + E reduced systolic blood pressure and heart-body weight ratio compared to vehicle and E alone (

Identifiants

pubmed: 34821697
pii: jcdd8110144
doi: 10.3390/jcdd8110144
pmc: PMC8621425
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Health and Medical Research Council
ID : GNT 632647
Organisme : National Health and Medical Research Council
ID : GNT 1164128

Références

Am J Kidney Dis. 1994 Sep;24(3):491-8
pubmed: 8079975
Curr Hypertens Rev. 2013 Feb;9(1):27-31
pubmed: 23971641
Clin J Am Soc Nephrol. 2010 Jan;5(1):102-9
pubmed: 20089507
Front Med (Lausanne). 2019 May 24;6:112
pubmed: 31179282
Kidney Int. 2014 Jun;85(6):1260-2
pubmed: 24875546
Kidney Int. 2018 Jul;94(1):40-48
pubmed: 29628139
PLoS One. 2016 Oct 10;11(10):e0164193
pubmed: 27723777
Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E125-32
pubmed: 15367398
Kidney Int. 2010 Jun;77(11):943-5
pubmed: 20467430
PLoS One. 2020 May 29;15(5):e0233705
pubmed: 32470067
Intern Med J. 2016 Aug;46(8):883-92
pubmed: 27553994
Eur J Pharmacol. 2004 Mar 19;488(1-3):239-45
pubmed: 15044057
Kidney Int. 2015 Jul;88(1):17-27
pubmed: 25786098
Nephrol Dial Transplant. 2013 Nov;28(11):2735-44
pubmed: 24013683
J Am Soc Nephrol. 2009 Sep;20(9):1888-93
pubmed: 19696226
Kidney Blood Press Res. 2007;30(3):129-44
pubmed: 17446713
Nat Rev Nephrol. 2009 Apr;5(4):221-8
pubmed: 19322187
Am J Nephrol. 2009;29(5):465-72
pubmed: 19033720
Am J Nephrol. 2012;36(4):362-70
pubmed: 23038404
Sci Rep. 2021 May 11;11(1):10014
pubmed: 33976330
Int J Mol Sci. 2021 Mar 12;22(6):
pubmed: 33809311
Clin J Am Soc Nephrol. 2012 Feb;7(2):358-65
pubmed: 22193236
Lancet. 2010 Nov 6;376(9752):1543-51
pubmed: 21055801
Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F141-9
pubmed: 21957179
Crit Rev Oncol Hematol. 2017 Apr;112:190-197
pubmed: 28325259
Toxicol Int. 2011 Jan;18(1):35-43
pubmed: 21430919
J Am Soc Nephrol. 2007 Jun;18(6):1796-806
pubmed: 17513326
Nutrients. 2020 Jul 15;12(7):
pubmed: 32679784
Nefrologia. 2016;36(1):10-8
pubmed: 26705959
Kidney Int. 1999 Dec;56(6):2181-90
pubmed: 10594794
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1315-22
pubmed: 20200094
N Engl J Med. 2014 Dec 11;371(24):2267-76
pubmed: 25399731
Front Physiol. 2014 Apr 03;5:122
pubmed: 24772087
Nephrol Dial Transplant. 2021 Apr 26;36(5):793-803
pubmed: 33416889
Am J Physiol Renal Physiol. 2004 Mar;286(3):F526-33
pubmed: 14600034
Kidney Blood Press Res. 2021;46(2):152-161
pubmed: 33756482
Am J Pathol. 2010 Aug;177(2):622-31
pubmed: 20616348
N Engl J Med. 2003 Jul 31;349(5):446-56
pubmed: 12890843
Curr Protein Pept Sci. 2019;20(10):984-995
pubmed: 31389312
Nephrology (Carlton). 2013 May;18(5):317-30
pubmed: 23448509
Nephrol Dial Transplant. 2017 Nov 1;32(11):1831-1840
pubmed: 28460073
Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F975-6
pubmed: 23804446
Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F574-82
pubmed: 23698116
PLoS One. 2019 Jan 2;14(1):e0209186
pubmed: 30601830
Kidney360. 2020 Jul;1(7):648-656
pubmed: 33305291
Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F647-57
pubmed: 22169009
Transplant Proc. 2012 Apr;44(3):642-5
pubmed: 22483459
N Engl J Med. 2012 Dec 20;367(25):2407-18
pubmed: 23121377
Nephrology (Carlton). 2017 Mar;22 Suppl 2:51-56
pubmed: 28429545

Auteurs

Priyanka S Sagar (PS)

Michael Stern Laboratory for Polycystic Kidney Disease, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia.
Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, NSW 2145, Australia.

Sayanthooran Saravanabavan (S)

Michael Stern Laboratory for Polycystic Kidney Disease, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia.
Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, NSW 2145, Australia.

Alexandra Munt (A)

Michael Stern Laboratory for Polycystic Kidney Disease, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia.
Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, NSW 2145, Australia.

Annette T Y Wong (ATY)

Michael Stern Laboratory for Polycystic Kidney Disease, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia.
Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, NSW 2145, Australia.

Gopala K Rangan (GK)

Michael Stern Laboratory for Polycystic Kidney Disease, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia.
Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, NSW 2145, Australia.

Classifications MeSH